BeyondSpring Stock Forecast, Price & News

BeyondSpring (NASDAQ:BYSI) Frequently Asked Questions

Is BeyondSpring a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BeyondSpring in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BeyondSpring stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BYSI, but not buy additional shares or sell existing shares.
View analyst ratings for BeyondSpring or view top-rated stocks.

How has BeyondSpring's stock been impacted by COVID-19?

BeyondSpring's stock was trading at $11.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BYSI stock has decreased by 71.1% and is now trading at $3.28.
View which stocks have been most impacted by COVID-19.

When is BeyondSpring's next earnings date?

BeyondSpring is scheduled to release its next quarterly earnings announcement on Friday, April 29th 2022.
View our earnings forecast for BeyondSpring.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) released its earnings results on Wednesday, December, 29th. The company reported ($0.47) EPS for the quarter, beating analysts' consensus estimates of ($0.58) by $0.11. BeyondSpring had a negative trailing twelve-month return on equity of 118.78% and a negative net margin of 6,057.17%.
View BeyondSpring's earnings history.

What price target have analysts set for BYSI?

6 brokers have issued 1 year price targets for BeyondSpring's stock. Their forecasts range from $5.00 to $65.00. On average, they expect BeyondSpring's share price to reach $30.00 in the next twelve months. This suggests a possible upside of 814.6% from the stock's current price.
View analysts' price targets for BeyondSpring or view top-rated stocks among Wall Street analysts.

Who are BeyondSpring's key executives?

BeyondSpring's management team includes the following people:

• Lan Huang, Chairman & Chief Executive Officer
• Richard J. Daly, Chief Operating Officer
• Elizabeth Adkins Czerepak, Chief Financial Officer
• G. Kenneth Lloyd, Chief Scientific Officer
• Ramon W. Mohanlal, Director, Chief Medical Officer, Executive VP-R&D

Who are some of BeyondSpring's key competitors?

Some companies that are related to BeyondSpring include Inventiva (IVA), Albireo Pharma (ALBO), Relmada Therapeutics (RLMD), LianBio (LIAN), Chimerix (CMRX), Tyra Biosciences (TYRA), Phathom Pharmaceuticals (PHAT), SIGA Technologies (SIGA), Deciphera Pharmaceuticals (DCPH), Lexicon Pharmaceuticals (LXRX), 2seventy bio (TSVT), BioXcel Therapeutics (BTAI), Intercept Pharmaceuticals (ICPT), LumiraDx (LMDX) and VBI Vaccines (VBIV).
View all of BYSI's competitors.

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), CorMedix (CRMD) and Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

(BYSI) raised $4 million in an initial public offering on Thursday, March 9th 2017. The company issued 200,000 shares at $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

What is BeyondSpring's stock symbol?

BeyondSpring trades on the NASDAQ under the ticker symbol "BYSI."

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by a number of institutional and retail investors. Top institutional investors include Cutler Group LP (0.00%).

Which institutional investors are selling BeyondSpring stock?

BYSI stock was sold by a variety of institutional investors in the last quarter, including Cutler Group LP.

How do I buy shares of BeyondSpring?

Shares of BYSI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BeyondSpring's stock price today?

One share of BYSI stock can currently be purchased for approximately $3.28.

How much money does BeyondSpring make?

BeyondSpring has a market capitalization of $128.27 million and generates $180 thousand in revenue each year. The company earns $-60.97 million in net income (profit) each year or ($1.92) on an earnings per share basis.

How many employees does BeyondSpring have?

BeyondSpring employs 91 workers across the globe.

What is BeyondSpring's official website?

The official website for BeyondSpring is www.beyondspringpharma.com.

Where are BeyondSpring's headquarters?

BeyondSpring is headquartered at 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005.

How can I contact BeyondSpring?

BeyondSpring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The company can be reached via phone at (646) 305-6387, via email at [email protected], or via fax at 1-646-882-4228.